Form4insider filings, from the source

SEC Form 4 · accession 0000842023-15-000003

BIO-TECHNE Corp · TECH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Marcel Veronneau
Officer — SVP - Clinical Controls
Period of report
Jun 8, 2015
Accepted (ET)
Jun 9, 2015 · 10:18 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJun 8, 2015F309$98.75D34,604D
Common StockJun 8, 2015M385$79.41A34,989D
Common Stockholding———6,831Iby Stock Bonus Plan

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock OptionF1$79.41Jun 8, 2015M385D—Jul 24, 2015Common Stock3850D
Stock OptionF1$62.46holding————Jul 23, 2016Common Stock494494D
Stock OptionF1$66.25holding————Apr 29, 2017Common Stock10,00010,000D
Stock OptionF1$58.40holding————Jul 29, 2017Common Stock1,2811,281D
Stock OptionF2$76.15holding————Jul 27, 2018Common Stock20,00020,000D
Stock OptionF1$76.15holding————Aug 27, 2018Common Stock1,1291,129D
Stock OptionF1$74.05holding————Jul 26, 2019Common Stock1,0971,097D
Stock OptionF3$76.02holding————Jul 31, 2020Common Stock15,00015,000D
Stock optionF4$94.35holding————Aug 12, 2021Common Stock15,00015,000D

Explanation of responses